Generic Drug Holdings, Inc. -- Moody's rates Generic Drug Holdings' new bank facility and affirms B2 CFR; outlook changed to negative

New York, July 31, 2013 -- Moody's Investors Service rated Generic Drug Holdings, Inc.'s new First Lien Term Loan and extended Secured Revolver at B1. Proceeds will be used to refinance existing term debt and mezzanine debt (unrated) as well as provide a special dividend to sponsors. At the same time, Moody's affirmed the company's B2 Corporate Family Rating and its B2-PD Probability of Default rating. The rating outlook is changed to negative from stable. Upon close of this transaction, the ratings on the existing Term Loan B and secured revolver will be withdrawn.

Vollständigen Artikel bei Moodys lesen